136 related articles for article (PubMed ID: 8355890)
1. Home infusion therapy: comparison of costs for intravenous immunoglobulin.
Bielory L; Long GC
N J Med; 1993 Jul; 90(7):512-5. PubMed ID: 8355890
[TBL] [Abstract][Full Text] [Related]
2. Home health care costs: intravenous immunoglobulin home infusion therapy.
Bielory L; Long GC
Ann Allergy Asthma Immunol; 1995 Mar; 74(3):265-8. PubMed ID: 7889384
[TBL] [Abstract][Full Text] [Related]
3. Impact of home infusion therapy on the Colorado Medicaid program budget.
Culbertson VL; Rhodes RS; Hill EP; Rhodes PJ
Am J Hosp Pharm; 1988 Jun; 45(6):1346-9. PubMed ID: 3137814
[TBL] [Abstract][Full Text] [Related]
4. A high-priced hookup.
Lord M
US News World Rep; 1994 May; 116(18):63-4, 67-9. PubMed ID: 10133811
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness issues for home i.v. therapy in the United States.
Allen R
Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplants. Managing BMT patients in alternate site health care settings with infusion therapy.
Buchsel PC
Contin Care; 1992; 11(1):27-9; 36. PubMed ID: 10150100
[No Abstract] [Full Text] [Related]
7. Home infusion therapy meets managed care: confrontation or cooperation.
Winters RW
Med Interface; 1994 Jul; 7(7):72-4, 85. PubMed ID: 10135994
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of home administration versus hospital administration of intravenous immunoglobulin].
RodrÃguez M; Procupet A; Heras J
Med Clin (Barc); 1991 Jan; 96(2):47-51. PubMed ID: 1902540
[TBL] [Abstract][Full Text] [Related]
9. Home i.v. therapy companies target insurers, HMOs for future growth.
Lutz S
Mod Healthc; 1987 Mar; 17(6):96, 99. PubMed ID: 10281052
[No Abstract] [Full Text] [Related]
10. Home intravenous drug therapy under Medicare.
Leader S
Pride Inst J Long Term Home Health Care; 1989; 8(3):8-14. PubMed ID: 10303820
[No Abstract] [Full Text] [Related]
11. Home care models for infusion therapy.
Brown JM
Caring; 1990 May; 9(5):24-7. PubMed ID: 10105439
[TBL] [Abstract][Full Text] [Related]
12. Home infusion depresses Medical Care revenues.
Lutz S
Mod Healthc; 1993 Jan; 23(3):12. PubMed ID: 10123645
[No Abstract] [Full Text] [Related]
13. Home care forum: cost viewpoints.
Weinstein SM
NITA; 1987; 10(6):401-9. PubMed ID: 3320816
[No Abstract] [Full Text] [Related]
14. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers.
Marren J; Rodgers B; Dishon M
Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818
[No Abstract] [Full Text] [Related]
15. Continental aims to sell home care lines for top dollar.
Lutz S
Mod Healthc; 1989 Oct; 19(42):6. PubMed ID: 10324707
[No Abstract] [Full Text] [Related]
16. Visiting nurse home pharmacy: a successful home pharmacy venture.
Terry LJ; Grigsby SF
Caring; 1990 May; 9(5):28-32. PubMed ID: 10105440
[TBL] [Abstract][Full Text] [Related]
17. Cost implications of home care on serious infections.
Rubinstein E
Hosp Formul; 1993 Jan; 28 Suppl 1():46-50. PubMed ID: 10123839
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
Simpson KN; Coughlin CM; Eron J; Bussel JB
Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
[TBL] [Abstract][Full Text] [Related]
19. A clinical productivity management system for home infusion therapy.
Grace LA; Illian AF; Rivers MP
J Intraven Nurs; 1993; 16(4):251-60. PubMed ID: 8410482
[TBL] [Abstract][Full Text] [Related]
20. Homedco and Abbey among companies that have viewed T2's books.
Burns J
Mod Healthc; 1994 Jan; 24(5):10. PubMed ID: 10131365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
